[1]
BettiolA., BolcatoJ., PiroloR., FranchinG., DeambrosisP., GiustiP. and ChinellatoA. 2016. Prevalence, Costs and Consequences of “Manovra AIFA” for ICS-LABA Treatment in Patients with Asthma or COPD: A Real-Practice Analysis. Global & Regional Health Technology Assessment. 3, 3 (Oct. 2016), 115-124. DOI:https://doi.org/10.33393/grhta.2016.417.